Fresenius SE & Co KGaA
(OTCQX: FSNUY)
|
4:59 PM UTC, 07/03/24 | |||
---|---|---|---|---|
Last: $7.81 | Change: +0.09 | %Change: +1.22% | Volume: 64,832 |
Open: | $ 7.70 | Volume: | 64,832 | |
---|---|---|---|---|
High: | $ 7.82 | Yield(%) | 0.00 | |
Low: | $ 7.70 | P/E Ratio (ttm): | n/a | |
Dividend ($): | 0.17 | Market Cap ($): | 17.19B | |
EPS ($) | -0.32 | Shares Out: | 2.25B |
% Price Change (last 4 weeks): | -3.90 |
---|---|
% Price Change (last 13 weeks): | 15.19 |
% Price Change (last 26 weeks): | -3.90 |
% Price Change (last 52 weeks): | 7.97 |
% Price Change (year to date): | -1.57 |
Return on Equity (%): | 1.78 |
---|---|
Return on Assets (%): | 0.58 |
Return on Invested Capital (%): | 3.64 |
Gross Profit Margin (%): | 22.68 |
---|---|
Net Profit Margin (%): | 1.58 |
Operating Profit Margin (%): | 5.81 |
|
|
50-day Moving Average: | $7.73 |
---|---|
200-day Moving Average: | $7.33 |
Avg. Daily Vol. (last 50 days): | 58,082 |
Avg. Daily Vol. (last 200 days): | 41,810 |
52-wk high: | $8.44 |
52-wk low: | $6.33 |
Bid: | $n/a |
Ask: | $n/a |
Fresenius SE & Co. KGaA is a healthcare group, which engages in the provision of products and services for dialysis, hospitals, and outpatient medical care. It operates through the following segments: Fresenius Medical Care, Fresenius Kabi, Fresenius Helios and Fresenius Vamed. The Fresenius Medical Care segment caters to individuals with renal diseases. The Fresenius Kabi segment specializes in lifesaving medicines and technologies. The Fresenius Helios offers expertise in inpatient and outpatient care as well as in telemedicine. The Fresenius Vamed segment manages projects and services for hospitals and other healthcare facilities. The company was founded by Eduard Fresenius on October 1, 1912 and is headquartered in Bad Homburg, Germany.
|
Fresenius SE & Co KGaA
Else-Kröner-Strasse 1 Bad Homburg HE 61352 Phone: 49.6172.608.0 Fax: 49.6172.608.2628 http://www.fresenius.de |
Earnings (1year) ($): | n/a |
---|---|
Annual Dividend ($): | 0.00 |
Current P/E Ratio (ttm): | n/a |
Book Value ($): | 9.32 |
Cash Flow ($): | 0.42 |
Price/Earnings (x): | n/a |
---|---|
Price/Sales (x): | 0.72 |
Price/Book (x): | 0.83 |
Price/Cash Flow (x): | 3.54 |
Quick Ratio (x): | 1.07 |
---|---|
Current Ratio (x): | 1.34 |
LT Debt/Equity (x): | 69.74 |
Total Debt/Equity (x): | 83.32 |